Approval · Notice of Compliance 21592 · 2018
SOMAVERT: Notice of Compliance 21592
Issued November 30, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21592
- Date
- November 30, 2018
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOMAVERT | Not yet assigned | — |
Medicinal ingredients
- PEGVISOMANT 10 MG per VIAL
- PEGVISOMANT 15 MG per VIAL
- PEGVISOMANT 20 MG per VIAL
- PEGVISOMANT 25 MG per VIAL
- PEGVISOMANT 30 MG per VIAL